Medical Council of Canada MCCQE Exam Dumps - Actual Questions Answers

This patient is competent and capable of making his own health decisions. A DNR order and naming a substitute decision-maker apply only when a patient lacks capacity. The next step is to discuss the suspected diagnosis with the patient and explore his preferences.

Toronto Notes 2023 – ELOM, Consent and Capacity:

“Competent patients retain full decision-making authority. Substitute decision-makers are only engaged when the patient lacks capacity. DNR applies to resuscitation, not other medical decisions.”

MCCQE1 Objectives – ELOM > Capacity, Consent, Advance Directives:

“Candidates must recognize that capable patients should be directly involved in decisions. Substitute decision-makers are not invoked unless the patient is incapable.”

Option A implies a breach of confidentiality without permission. Option C is premature. Option D bypasses informed consent. Option E misinterprets the DNR’s scope.

====================================================

This patient has been assessed as incapable of making the decision regarding dialysis. MCCQE ELOM objectives emphasize that when a patient lacks decision-making capacity, treatment decisions must be made by a legally authorized substitute decision-maker (SDM) according to provincial/territorial hierarchy. The appropriate next step is to determine whether a formal SDM has been appointed (e.g., power of attorney for personal care) or identify the legally ranked default SDM.

Although the wife may often be the default SDM, this depends on jurisdiction and whether a formal representative has been designated. It is inappropriate to automatically follow the son’s wishes, as he may not be the legal SDM. Nor should the physician impose their own recommendation without engaging the proper decision-making process. A large family meeting may be helpful later but does not replace identifying the legally authorized decision-maker.

Once identified, the SDM must make decisions based on the patient’s prior capable wishes or, if unknown, the patient’s best interests. Properly establishing the SDM ensures ethical and legal compliance in incapacity situations.

Ramipril, an ACE inhibitor, is contraindicated in pregnancy due to risks of fetal renal dysgenesis, oligohydramnios, and fetal death, especially in the second and third trimesters.

Toronto Notes 2023 – Obstetrics, Hypertensive Disorders of Pregnancy:

“ACE inhibitors and ARBs are contraindicated in pregnancy due to their teratogenic potential and adverse fetal effects.”

MCCQE1 Objectives – Obstetrics > Hypertension in Pregnancy:

“Candidates must identify safe antihypertensives during pregnancy and contraindicated medications such as ACE inhibitors and ARBs.”

Methyldopa, labetalol, nifedipine, and hydralazine are considered safe and are commonly used in pregnancy.

====================================================